Amiot A, Kirchgesner J, Alric H, Treton X, et al. Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor. Clin Res Hepatol Gastroenterol 2025 Dec 5:102741.
PMID: 41354393